Fig. 1From: Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetesThe underlying mechanisms of AD-MSC effect on T2DM. AD-MSCs improve T2DM through promotion pancreatic islet β cell function, amelioration of insulin resistance of peripheral tissue, and regulation hepatic glucose metabolismBack to article page